Advertisement
Australia markets closed
  • ALL ORDS

    7,837.40
    -100.10 (-1.26%)
     
  • ASX 200

    7,575.90
    -107.10 (-1.39%)
     
  • AUD/USD

    0.6551
    +0.0028 (+0.43%)
     
  • OIL

    83.78
    +0.21 (+0.25%)
     
  • GOLD

    2,361.00
    +18.50 (+0.79%)
     
  • Bitcoin AUD

    98,221.03
    +815.17 (+0.84%)
     
  • CMC Crypto 200

    1,389.44
    -7.09 (-0.51%)
     
  • AUD/EUR

    0.6095
    +0.0022 (+0.37%)
     
  • AUD/NZD

    1.0984
    +0.0027 (+0.24%)
     
  • NZX 50

    11,805.09
    -141.34 (-1.18%)
     
  • NASDAQ

    17,430.50
    -96.30 (-0.55%)
     
  • FTSE

    8,108.68
    +29.82 (+0.37%)
     
  • Dow Jones

    38,085.80
    -375.12 (-0.98%)
     
  • DAX

    18,047.87
    +130.59 (+0.73%)
     
  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

Ashland's (ASH) Earnings Beat Estimates in Q1, Revenues Lag

Ashland Global Holdings Inc. ASH recorded profits of $40 million or 73 cents per share in the first quarter of fiscal 2023 (ending Dec 31, 2022), down from $48 million or 83 cents in the prior-year quarter.

Barring one-time items, adjusted earnings came in at 97 cents per share, up from the year-ago quarter’s figure of 88 cents. It topped the Zacks Consensus Estimate of 95 cents.

Sales rose around 3% year over year to $525 million. It missed the Zacks Consensus Estimate of $525.9 million. The top line was driven mainly by disciplined pricing actions leading to a recovery in costs as well as strong demand for pharmaceutical ingredients, partly offset by demand weakness in China due COVID-19 restrictions and significant inventory destocking particularly in China and Europe.

 

Ashland Inc. Price, Consensus and EPS Surprise

 

Ashland Inc. Price, Consensus and EPS Surprise
Ashland Inc. Price, Consensus and EPS Surprise

Ashland Inc. price-consensus-eps-surprise-chart | Ashland Inc. Quote

 

Segment Highlights

Life Sciences: Sales in the segment were up 22% year over year to $207 million in the reported quarter, aided by double-digit growth to pharmaceutical customers reflecting cost recovery and strong demand.

Personal Care: Sales in the division fell 6% year over year to $138 million. Disciplined pricing was offset by lower sales in China mainly due to COVID-19 policies and inventory destocking within the distribution channel.
 
Specialty Additives: Sales in the segment fell 8% year over year to $143 million, hurt by the impact of COVID-19 restrictions in China and inventory destocking in China and Europe.

Intermediates: Sales in the segment went up 2% year over year to $54 million, led by higher merchant-market prices.

Financials

Cash and cash equivalents were $532 million at the end of the quarter, up around 174% year over year. Long-term debt was $1,316 million, down around 17% year over year.

Cash flows used by operating activities were $29 million in the reported quarter.

Outlook

Ashland continues to expect sales in the range of $2.5-$2.7 billion for fiscal 2023. It also anticipates adjusted EBITDA to be within the $600-$650 million range for the full fiscal.

Price Performance

Shares of Ashland have gained 12.5% in the past year compared with a 20.6% decline of the industry.

ADVERTISEMENT

 

Zacks Investment Research
Zacks Investment Research


Image Source: Zacks Investment Research

 

Zacks Rank & Other Key Picks

Ashland currently carries a Zacks Rank #3 (Hold).

Better-ranked stocks worth considering in the basic materials space include Steel Dynamics, Inc. STLD, Commercial Metals Company CMC and Agnico Eagle Mines Limited AEM.

Steel Dynamics currently sports a Zacks Rank #1 (Strong Buy). The Zacks Consensus Estimate for STLD's current-year earnings has been revised 0.4% upward in the past 60 days. You can see the complete list of today’s Zacks #1 Rank stocks here.

Steel Dynamics’ earnings beat the Zacks Consensus Estimate in each of the last four quarters. It has a trailing four-quarter earnings surprise of roughly 11.3%, on average. STLD has rallied around 104% in a year.

Commercial Metals currently carries a Zacks Rank #1. The consensus estimate for CMC's current-year earnings has been revised 9.8% upward in the past 60 days.

Commercial Metals’ earnings beat the Zacks Consensus Estimate in each of the last four quarters. It has a trailing four-quarter earnings surprise of roughly 16.7%, on average. CMC has gained around 53% in a year.

Agnico Eagle currently carries a Zacks Rank #2 (Buy). The Zacks Consensus Estimate for AEM’s current-year earnings has been revised 0.4% upward in the past 60 days.

Agnico Eagle beat Zacks Consensus Estimate in three of the last four quarters. It delivered a trailing four-quarter earnings surprise of 26.4% on average. AEM’s shares have gained roughly 16% in the past year.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Steel Dynamics, Inc. (STLD) : Free Stock Analysis Report

Ashland Inc. (ASH) : Free Stock Analysis Report

Agnico Eagle Mines Limited (AEM) : Free Stock Analysis Report

Commercial Metals Company (CMC) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research